263 related articles for article (PubMed ID: 31776787)
21. Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network.
Dreyling M; Kluin-Nelemans HC; Beà S; Klapper W; Vogt N; Delfau-Larue MH; Hutter G; Cheah C; Chiappella A; Cortelazzo S; Pott C; Hess G; Visco C; Vitolo U; Klener P; Aurer I; Unterhalt M; Ribrag V; Hoster E; Hermine O;
Leuk Lymphoma; 2013 Apr; 54(4):699-707. PubMed ID: 23020649
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic features and management of blastoid variant of mantle cell lymphoma.
Shrestha R; Bhatt VR; Guru Murthy GS; Armitage JO
Leuk Lymphoma; 2015; 56(10):2759-67. PubMed ID: 25747972
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop.
Gordon LI; Bernstein SH; Jares P; Kahl BS; Witzig TE; Dreyling M
Leuk Lymphoma; 2014 Oct; 55(10):2262-70. PubMed ID: 24512319
[TBL] [Abstract][Full Text] [Related]
24. Recent advances and future directions in mantle cell lymphoma research: report of the 2016 mantle cell lymphoma consortium workshop.
Kahl BS; Dreyling M; Gordon LI; Quintanilla-Martinez L; Sotomayor EM
Leuk Lymphoma; 2017 Jul; 58(7):1561-1569. PubMed ID: 28140709
[TBL] [Abstract][Full Text] [Related]
25. Mantle cell lymphoma in the ocular adnexal region.
Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
[TBL] [Abstract][Full Text] [Related]
26. [Mantle cell lymphoma].
Khosravi Shahi P; Del Castillo Rueda A; Pérez Manga G
An Med Interna; 2007 Mar; 24(3):142-5. PubMed ID: 17590138
[TBL] [Abstract][Full Text] [Related]
27. Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index.
Kimura Y; Sato K; Imamura Y; Arakawa F; Kiyasu J; Takeuchi M; Miyoshi H; Yoshida M; Niino D; Sugita Y; Morito T; Yoshino T; Nakamura S; Ohshima K
Cancer Sci; 2011 Sep; 102(9):1734-41. PubMed ID: 21609366
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in mantle cell lymphoma: report of the 2012 Mantle Cell Lymphoma Consortium Workshop.
Williams ME; Bernstein SH; Jares P; Kahl BS; Witzig TE; Gordon LI
Leuk Lymphoma; 2013 Sep; 54(9):1882-90. PubMed ID: 23363271
[TBL] [Abstract][Full Text] [Related]
29. Mantle cell lymphoma: state of the art.
Skarbnik AP; Goy AH
Clin Adv Hematol Oncol; 2015 Jan; 13(1):44-55. PubMed ID: 25679973
[TBL] [Abstract][Full Text] [Related]
30. Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.
Beà S; Amador V
Curr Oncol Rep; 2017 Jun; 19(6):43. PubMed ID: 28466437
[TBL] [Abstract][Full Text] [Related]
31. [Palpable mantel cell lymphoma in the breast].
Boullanger N; Renou P; Dugay J; Boyer J; de Yberlucea LR; Combe M; Coulon MA
Presse Med; 2001 Feb; 30(4):163-5. PubMed ID: 11229304
[TBL] [Abstract][Full Text] [Related]
32. Pathologic diagnosis of mantle cell lymphoma.
Lai R; Medeiros LJ
Clin Lymphoma; 2000 Dec; 1(3):197-206; discussion 207-8. PubMed ID: 11707830
[TBL] [Abstract][Full Text] [Related]
33. Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients.
Righi S; Pileri S; Agostinelli C; Bacci F; Spagnolo S; Sabattini E
Hum Pathol; 2017 Jan; 59():94-101. PubMed ID: 27720733
[TBL] [Abstract][Full Text] [Related]
34. [Mantle cell lymphoma: case report].
Méhes L; Telek B; Udvardy M; Schlammadinger A; és Rejto L
Orv Hetil; 2008 Aug; 149(31):1471-4. PubMed ID: 18632508
[TBL] [Abstract][Full Text] [Related]
35. Therapies for mantle cell lymphoma: current challenges and a brighter future.
Skarbnik AP; Smith MR
Discov Med; 2013 Mar; 15(82):177-87. PubMed ID: 23545046
[TBL] [Abstract][Full Text] [Related]
36. Open questions in the management of mantle cell lymphoma.
Li ZM; Zucca E; Ghielmini M
Cancer Treat Rev; 2013 Oct; 39(6):602-9. PubMed ID: 23415066
[TBL] [Abstract][Full Text] [Related]
37. Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.
Klener P; Fronkova E; Berkova A; Jaksa R; Lhotska H; Forsterova K; Soukup J; Kulvait V; Vargova J; Fiser K; Prukova D; Alam M; Calvin Lenyeletse Maswabi B; Michalova K; Zemanova Z; Jancuskova T; Pekova S; Trneny M
Int J Cancer; 2016 Nov; 139(10):2252-60. PubMed ID: 27407063
[TBL] [Abstract][Full Text] [Related]
38. Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.
Williams ME; Connors JM; Dreyling MH; Gascoyne RD; Kahl BS; Leonard JP; Press OW; Wilson WH
Leuk Lymphoma; 2011 Jan; 52(1):24-33. PubMed ID: 21133727
[TBL] [Abstract][Full Text] [Related]
39. CD5-negative Mantle Cell Lymphoma: Clinicopathologic Correlations and Outcome in 58 Patients.
Miao Y; Lin P; Saksena A; Xu J; Wang M; Romaguera J; Yin CC; Medeiros LJ; Li S
Am J Surg Pathol; 2019 Aug; 43(8):1052-1060. PubMed ID: 31045891
[TBL] [Abstract][Full Text] [Related]
40. Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma.
Wlodarska I; Meeus P; Stul M; Thienpont L; Wouters E; Marcelis L; Demuynck H; Rummens JL; Madoe V; Hagemeijer A
Leukemia; 2004 Oct; 18(10):1705-10. PubMed ID: 15306823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
